NCT07101822
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07101822
Title A PHASE II, RANDOMIZED STUDY TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1ST LINE PLATINUM-BASED CHEMOTHERAPY IN ADVANCED/RECURRENT PENILE CANCER (BRAVA PENILE)
Acronym BRAVA PENILE
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Hospital Israelita Albert Einstein
Indications
Therapies
Age Groups: adult | senior
Covered Countries BRA


No variant requirements are available.